- About HHR
Published November 5, 2013
We are writing to support the claim made by Mpinga et al. in their article Traditional/alternative medicines and the right to health: Key elements for a Convention on Global Health. In their discussion of the strengths and challenges associated with the use of “non-conventional medicines” (NCMs), the authors describe such therapies as being not only “cultural products, vectors of knowledge, but also a form of connection among people in the society.”
We agree with the authors’ claim that NCMs play a crucial role in maintaining communities. This rings especially true for societies in developing countries affected by globalization. One of the changes associated with globalization is an increased role for free markets and private actors (e.g. corporations, individual entrepreneurs, etc.), and a reduced role for governments in policymaking and public spending (e.g. health, housing, education, etc.).1
In most low- and middle- income countries (LMICs) with poor health indicators, this means that the primary entity with a legal obligation to develop and maintain a nation’s health infrastructure (i.e. the government) is becoming less rather than more involved with addressing national health problems in a systematic way.2 Therefore, underserved communities must look for alternative means of addressing their health challenges. Because NCMs are in widespread use and rarely rely on government investment, it is crucial (as the authors argue) that any serious global health strategy integrate them, even if there remain challenges regarding their safety, efficacy, and regulation. The challenges notwithstanding, including NCMs in a global health treaty not only improves health outcomes but also strengthens communities that face declining government health expenditures.
Ibrahim Garba, MA, JD, LLM, is Satcher Health Policy Leadership Fellow at the Morehouse School of Medicine in Atlanta, Georgia, USA.
Nicolas Bakinde, MD, PhD, is Assistant Professor of Medicine at the Morehouse School of Medicine in Atlanta, Georgia, USA.
Please address correspondence to the authors c/o Ibrahim Garba, Satcher Health Leadership Institute, Louis W. Sullivan National Center for Primary Care, Suite 238, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310. Email: email@example.com.
1. World Health Organization, 25 Questions and Answers on Health & Human Rights (Geneva: WHO, July 2002), p. 26. Available at http://www.who.int/hhr/information/25%20Questions%20and%20Answers%20on%20Health%20and%20Human%20Rights.pdf.
2. United Nations, International Covenant on Economic, Social and Cultural Rights (1966), Article 12. Available at http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx.
Papers in Press
How Drug Control Policy and Practice Undermine Access to Controlled Medicines
Naomi Burke-Shyne, Joanne Csete, Duncan Wilson, Edward Fox, Daniel Wolfe, and Jennifer J. K. Rasanathan
Drug Policies and Indigenous Peoples
Julian Burger and Mary Kapron
International Guidelines on Human Rights and Drug Control: A Tool for Securing Women’s Rights in Drug Control Policy
Rebecca Schleifer and Luciana Pol
Mechanisms of Accountability for the Realization of the Right to Health in China
Shengnan Qiu and Gillian MacNaughton
The Child’s Right to Protection From Drugs: Understanding History to Move Forward
The Case for International Guidelines on Human Rights and Drug Control
Rick Lines, Richard Elliott, Julie Hannah, Rebecca Schleifer, Tenu Avafia, and Damon Barrett
Letter to the Editor: Human Rights, TB, Legislation and Jurisprudence
O. B. K. Dingake
UNstoppable: How Advocates Persevered in the Fight for Justice for Haitian Cholera Victims